Barbara Wilmarth

646 total citations
9 papers, 442 citations indexed

About

Barbara Wilmarth is a scholar working on Hematology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Barbara Wilmarth has authored 9 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Neurology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Barbara Wilmarth's work include Chronic Myeloid Leukemia Treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Nuclear Receptors and Signaling (3 papers). Barbara Wilmarth is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Nuclear Receptors and Signaling (3 papers). Barbara Wilmarth collaborates with scholars based in United States, United Kingdom and Germany. Barbara Wilmarth's co-authors include Yasar Torres‐Yaghi, Fernando Pagán, Charbel Moussa, Michaeline Hebron, Jaeil Ahn, Abigail Lawler, Sara Matar, Sean Rogers, Zhaoxia Li and Xu Huang and has published in prestigious journals such as Neurology, Neuropsychologia and Movement Disorders.

In The Last Decade

Barbara Wilmarth

9 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Wilmarth United States 5 274 164 135 102 60 9 442
Abigail Lawler United States 5 255 0.9× 157 1.0× 165 1.2× 120 1.2× 63 1.1× 8 484
Yasar Torres‐Yaghi United States 10 345 1.3× 196 1.2× 194 1.4× 155 1.5× 71 1.2× 29 640
Benedikt Bader Germany 13 175 0.6× 175 1.1× 277 2.1× 163 1.6× 111 1.9× 28 574
Aaron Carlson United States 8 364 1.3× 219 1.3× 430 3.2× 262 2.6× 23 0.4× 30 802
Stephanie L. Celano United States 4 264 1.0× 139 0.8× 106 0.8× 141 1.4× 6 0.1× 6 453
Chaohui Zhao United States 7 189 0.7× 143 0.9× 113 0.8× 136 1.3× 16 0.3× 11 514
Lawrence Van Helleputte Belgium 9 96 0.4× 147 0.9× 68 0.5× 247 2.4× 11 0.2× 12 433
Zhanyun Lv China 13 196 0.7× 107 0.7× 61 0.5× 222 2.2× 8 0.1× 23 456
Flora Berisha United States 5 149 0.5× 54 0.3× 247 1.8× 130 1.3× 7 0.1× 9 411
Junbing Wu China 11 105 0.4× 135 0.8× 68 0.5× 264 2.6× 10 0.2× 14 512

Countries citing papers authored by Barbara Wilmarth

Since Specialization
Citations

This map shows the geographic impact of Barbara Wilmarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Wilmarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Wilmarth more than expected).

Fields of papers citing papers by Barbara Wilmarth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Wilmarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Wilmarth. The network helps show where Barbara Wilmarth may publish in the future.

Co-authorship network of co-authors of Barbara Wilmarth

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Wilmarth. A scholar is included among the top collaborators of Barbara Wilmarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Wilmarth. Barbara Wilmarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, et al.. (2025). Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with Nilotinib. Journal of Clinical Medicine. 14(12). 4245–4245. 1 indexed citations
2.
Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, et al.. (2022). Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12296–e12296. 10 indexed citations
3.
Estabrooke, Ivy V., João Veríssimo, Karim Johari, et al.. (2020). Can sex influence the neurocognition of language? Evidence from Parkinson's disease. Neuropsychologia. 148. 107633–107633. 4 indexed citations
4.
Pagán, Fernando, Barbara Wilmarth, Yasar Torres‐Yaghi, et al.. (2020). Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease. Movement Disorders. 36(3). 740–749. 38 indexed citations
5.
Fowler, Alan J., Yasar Torres‐Yaghi, Fernando Pagán, et al.. (2020). Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the CSF of individuals with Parkinson’s disease (5357). Neurology. 94(15_supplement). 4 indexed citations
6.
Pagán, Fernando, Michaeline Hebron, Barbara Wilmarth, et al.. (2019). Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease. Pharmacology Research & Perspectives. 7(2). e00470–e00470. 73 indexed citations
7.
Pagán, Fernando, Michaeline Hebron, Barbara Wilmarth, et al.. (2019). Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease. JAMA Neurology. 77(3). 309–309. 118 indexed citations
8.
Pagán, Fernando, Yasar Torres‐Yaghi, Michaeline Hebron, et al.. (2016). Nilotinib Improves Motor Skills, Cognition and Autonomic Function in Open-Label Phase I Clinical Trial in Parkinsons Disease with Dementia and Lewy Body Dementia (I1.008). Neurology. 86(16_supplement). 1 indexed citations
9.
Pagán, Fernando, Michaeline Hebron, Yasar Torres‐Yaghi, et al.. (2016). Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies. Journal of Parkinson s Disease. 6(3). 503–517. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abigail Lawler Breakdown of academic impact, for papers by Yasar Torres‐Yaghi Breakdown of academic impact, for papers by Benedikt Bader Breakdown of academic impact, for papers by Aaron Carlson Breakdown of academic impact, for papers by Stephanie L. Celano Breakdown of academic impact, for papers by Chaohui Zhao Breakdown of academic impact, for papers by Lawrence Van Helleputte Breakdown of academic impact, for papers by Zhanyun Lv Breakdown of academic impact, for papers by Flora Berisha Breakdown of academic impact, for papers by Junbing Wu
Rankless by CCL
2026